Semir Vranić
Semir Vranić
Ostala imenaSemir Vranic
CMED, Qatar University & Academy of Sciences and Arts of Bosnia&Herzegovina
Potvrđena adresa e-pošte na - Početna stranica
The role of the Hedgehog signaling pathway in cancer: A comprehensive review
AM Skoda, D Simovic, V Karin, V Kardum, S Vranic, L Serman
Bosnian journal of basic medical sciences, 2018
The 2019 WHO classification of tumours of the breast
PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ...
Histopathology 77 (2), 2020
Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type
Z Gatalica, C Snyder, T Maney, A Ghazalpour, DA Holterman, N Xiao, ...
Cancer epidemiology, biomarkers & prevention 23 (12), 2965-2970, 2014
Molecular characterization of cancers with NTRK gene fusions
Z Gatalica, J Xiu, J Swensen, S Vranic
Modern Pathology 32 (1), 147-153, 2019
Medical management of abortion
World Health Organization
World Health Organization, 2019
Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements
A Malki, RA ElRuz, I Gupta, A Allouch, S Vranic, AE Al Moustafa
International journal of molecular sciences 22 (1), 130, 2020
A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells
XT Zhang, LG Kang, L Ding, S Vranic, Z Gatalica, ZY Wang
Oncogene 30 (7), 770-780, 2011
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
Z Gatalica, S Vranic, J Xiu, J Swensen, S Reddy
Familial cancer 15 (3), 405-412, 2016
WHO classification of tumours
WHO Classification of Tumours Editorial Board
Digestive system tumours, 2019
EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast
S Vranic, O Tawfik, J Palazzo, N Bilalovic, E Eyzaguirre, LMJ Lee, ...
Modern pathology 23 (5), 644-653, 2010
Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1
U Joneja, S Vranic, J Swensen, R Feldman, W Chen, J Kimbrough, ...
Journal of clinical pathology, jclinpath-2016-203874, 2017
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: a new clinical paradigm in the treatment of triple-negative breast cancer
FS Cyprian, S Akhtar, Z Gatalica, S Vranic
Bosnian Journal of Basic Medical Sciences 19 (3), 227, 2019
Predictive biomarker profiling of> 6000 breast cancer patients shows heterogeneity in TNBC, with treatment implications
SZ Millis, Z Gatalica, J Winkler, S Vranic, J Kimbrough, S Reddy, ...
Clinical breast cancer 15 (6), 473-481. e3, 2015
PD-L1 status in breast cancer: Current view and perspectives
S Vranic, FS Cyprian, Z Gatalica, J Palazzo
Seminars in cancer biology 72, 146-154, 2021
Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy
Z Gatalica, J Xiu, J Swensen, S Vranic
European journal of cancer 94, 179-186, 2018
Apocrine carcinoma of the breast: a comprehensive review
S Vranic, F Schmitt, A Sapino, JL Costa, S Reddy, M Castro, Z Gatalica
F. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de …, 2013
Soft tissue and bone tumours WHO classification of tumours/volume 3
H Moch
WHO classification of tumours 3, 2020
Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1
Z Gatalica, N Bilalovic, JP Palazzo, RP Bender, J Swensen, SZ Millis, ...
Oncotarget 6 (23), 19819, 2015
Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases
Z Gatalica, SZ Millis, S Vranic, R Bender, GD Basu, A Voss, DD Von Hoff
Oncotarget 5 (23), 12440, 2014
Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin
SZ Millis, D Bryant, G Basu, R Bender, S Vranic, Z Gatalica, NJ Vogelzang
Clinical genitourinary cancer 13 (1), e37-e49, 2015
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20